Daptomycin

Daptomycin for Injection is indicated for the treatment of the infections listed below.
 
Complicated Skin and Skin Structure Infections
Complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).
 
Staphylococcus aureus Bloodstream Infections (Bacteremia), Including Those with Right-Sided Infective Endocarditis, Caused by Methicillin-Susceptible and Methicillin-Resistant Isolates.
Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.
 
Limitations of Use
Daptomycin for Injection is not indicated for the treatment of pneumonia.
Daptomycin for Injection is not indicated for the treatment of left-sided infective endocarditis due to S. aureus. The clinical trial of Daptomycin for Injection in patients with S. aureus bloodstream infections included limited data from patients with left-sided infective endocarditis; outcomes in these patients were poor [see Clinical Studies. Daptomycin for Injection has not been studied in patients with prosthetic valve endocarditis.
 
For indications, dosing and other information, please refer to the prescribing information.
 

Daptomycin ‐ Pfizer Injectables

Size:
500 mg, 10 mL
NDC #:
00409-0106-01
Download:
PI

Daptomycin ‐ Teva

Size:
500 mg, 10 mL
NDC #:
00703-0125-01
Download:
PI